GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
J

JD Health International 6618.HK · HKD

Consumer Staples · HKEX · 🇭🇰 Hong Kong

Compare

43.00

-0.60%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥85.36bn

FY2017FY2025

Net income

CN¥6.25bn

FY2017FY2025

Free cash flow

CN¥11.38bn

FY2017FY2025

Shareholders' equity

CN¥69.85bn

FY2017FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
RevenueCN¥85.36bnCN¥58.16bnCN¥53.53bnCN¥54.32bnCN¥35.66bnCN¥22.53bnCN¥12.60bnCN¥9.49bnCN¥6.45bn
Gross profitCN¥21.15bnCN¥13.31bnCN¥11.87bnCN¥11.50bnCN¥8.36bnCN¥5.72bnCN¥3.27bnCN¥2.30bnCN¥1.60bn
Research and developmentCN¥1.90bnCN¥1.33bnCN¥1.23bnCN¥1.24bnCN¥1.04bnCN¥707.9mCN¥393.1mCN¥253.7mCN¥142.6m
Operating incomeCN¥4.41bnCN¥1.16bnCN¥700.7m−CN¥168.7m−CN¥1.63bnCN¥408.6mCN¥501.6mCN¥356.9mCN¥297.9m
Net incomeCN¥6.25bnCN¥4.16bnCN¥2.14bnCN¥441.8m−CN¥1.25bn−CN¥20.03bn−CN¥1.13bnCN¥249.8mCN¥207.5m
Diluted earnings per share1.951.320.680.14-0.40-8.83-0.430.080.07

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsCN¥94.86bnCN¥82.84bnCN¥74.72bnCN¥71.22bnCN¥55.79bnCN¥51.13bnCN¥10.08bnCN¥1.37bnCN¥1.06bn
Cash and short-term investmentsCN¥55.96bnCN¥59.55bnCN¥47.91bnCN¥55.41bnCN¥48.80bnCN¥46.84bnCN¥7.39bnCN¥18.8mCN¥8.6m
Total liabilitiesCN¥25.01bnCN¥18.64bnCN¥17.34bnCN¥19.17bnCN¥9.47bnCN¥5.51bnCN¥10.62bnCN¥503.2mCN¥289.1m
DebtCN¥240.2mCN¥258.0mCN¥215.0mCN¥199.4mCN¥201.3mCN¥90.0mCN¥7.60bnCN¥3.1mCN¥3.3m
Shareholders' equityCN¥69.85bnCN¥64.19bnCN¥57.36bnCN¥52.05bnCN¥46.32bnCN¥45.62bn−CN¥533.5mCN¥870.8mCN¥770.1m
Shares outstanding3,203m3,165m3,165m3,149m3,098m2,268m2,638m3,127m3,127m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operationsCN¥11.55bnCN¥4.33bnCN¥5.35bnCN¥6.86bnCN¥3.99bnCN¥4.30bnCN¥475.9mCN¥217.6mCN¥42.0m
Capital spending−CN¥171.0m−CN¥46.4m−CN¥80.6m−CN¥46.7m−CN¥583.7m−CN¥18.2m−CN¥6.0m−CN¥2.8m−CN¥10.0m
Free cash flowCN¥11.38bnCN¥4.29bnCN¥5.27bnCN¥6.82bnCN¥3.40bnCN¥4.28bnCN¥469.9mCN¥214.8mCN¥32.0m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
RevenueCN¥46.87bnCN¥44.34bnCN¥41.02bnCN¥29.82bnCN¥28.34bnCN¥26.42bnCN¥31.51bnCN¥30.81bn
Gross profitCN¥12.25bnCN¥10.82bnCN¥10.33bnCN¥6.61bnCN¥6.70bnCN¥5.66bnCN¥7.21bnCN¥6.37bn
Operating incomeCN¥3.62bnCN¥1.94bnCN¥2.47bnCN¥127.9mCN¥1.04bn−CN¥248.4mCN¥1.02bn−CN¥225.7m
Net incomeCN¥3.94bnCN¥3.23bnCN¥3.02bnCN¥2.12bnCN¥2.04bnCN¥580.5mCN¥1.81bnCN¥182.0m
Diluted earnings per share1.231.010.940.670.640.180.570.06
Cash from operations—CN¥4.72bnCN¥7.26bnCN¥2.10bnCN¥2.23bnCN¥4.92bnCN¥427.0mCN¥4.24bn
Capital spending—−CN¥132.0m−CN¥41.0m−CN¥9.0m−CN¥9.0m−CN¥25.0m−CN¥45.0m−CN¥21.0m
Free cash flow—CN¥4.59bnCN¥7.22bnCN¥2.09bnCN¥2.22bnCN¥4.90bnCN¥382.0mCN¥4.22bn
Total assetsCN¥97.81bnCN¥94.86bnCN¥91.19bnCN¥82.84bnCN¥78.12bnCN¥74.72bnCN¥71.30bnCN¥71.22bn
Cash and short-term investmentsCN¥55.11bnCN¥55.96bnCN¥57.31bnCN¥59.55bnCN¥55.69bnCN¥47.91bnCN¥58.05bnCN¥55.41bn
DebtCN¥308.7mCN¥739.2mCN¥499.4mCN¥300.3mCN¥253.0mCN¥110.8mCN¥251.9mCN¥231.8m
Shareholders' equityCN¥71.41bnCN¥69.85bnCN¥67.38bnCN¥64.19bnCN¥60.59bnCN¥57.36bnCN¥56.58bnCN¥52.05bn

Financial ratios

Data as of 7 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin24.8%22.9%22.2%21.2%23.5%25.4%
Operating margin5.2%2.0%1.3%-0.3%-4.6%1.8%
Net margin7.3%7.2%4.0%0.8%-3.5%-88.9%
Return on equity8.9%7.5%4.3%0.8%-2.7%-43.9%
Return on assets6.6%5.8%3.3%0.6%-2.2%-39.2%
Free cash flow yield8.6%3.8%4.0%5.1%3.5%4.5%
Revenue growth26.3%8.6%14.5%52.3%58.3%78.8%
Earnings growth29.2%94.3%463.5%-135.4%-93.8%1673.4%
Current ratio2.72x3.77x3.28x3.45x5.71x9.12x
Debt to equity0.00x0.00x0.00x0.00x0.00x0.00x
Equity ratio73.6%77.5%76.8%73.1%83.0%89.2%
Interest coverage342.22x141.92x73.88x-15.95x-234.05x102.93x
R&D as a share of sales2.2%2.3%2.3%2.3%2.9%3.1%
Buybacks as a share of market value-1.2%0.0%-0.5%-1.6%-36.6%14.0%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue16.2%30.6%—
Operating income—61.0%—
Net income141.8%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin24.0%23.0%23.2%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings25.118.951.1449.6-134.9-15.0
Price to sales1.81.42.03.64.713.3

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.